Pharmaceutical Defence Limited (PDL) is a member owned organisation supporting around 31,000 pharmacist members and the pharmacy profession. The leading risk advisors to the profession,
Notice is hereby given that the 110th Annual General Meeting of Pharmaceutical Defence Limited will be a hybrid meeting, both in person at Suite 3,
Disclaimer: This article was published in 2022 and reflects the information available at that time. PDL continues to see notifications involving forged prescriptions and
Disclaimer: This article was published in 2022 and reflects the information available at that time. PDL has recently received several incident reports where the
Disclaimer: This article was published in 2022 and reflects the information available at that time. It is no surprise that the top four drugs
The following vacancies will occur as of the date of the next Annual General Meeting to be held on 20 October 2022 One Director
Disclaimer: This article was published in 2022 and reflects the information available at that time. Schedule 8 medicines, in particular opioids, are often involved
Disclaimer: This article was published in 2022 and reflects the information available at that time. Lapsed Professional Indemnity insurance arrangements – Section 130(3)(a)(iii), National
Disclaimer: This article was published in 2022 and reflects the information available at that time. PDL Professional Officers have observed an increase in formal
Disclaimer: This article was published in 2022 and reflects the information available at that time. PDL representatives Gilbert Yeates (Qld Director) and Gary West
Pharmaceutical Defence Limited (PDL) acknowledges the Traditional Owners of Country throughout Australia and their continuing connection to land, waters and community. We pay our respects to the people, the cultures and the Elders past and present.